Moreover, numerous researches have shown that PGRMC1 is overexpressed in chemo‐resistant tumour cells, such as doxorubicin‐resistant and camptothecin‐resistant breast cancer cells, cisplatin‐resistant ovarian cancer cells and doxorubicin‐resistant uterine cancer cells.35 Here, PGRMC1 is linked to breast carcinoma.